Transphorm Q4 Sales $3.20M Miss $4.67M Estimate
Portfolio Pulse from Benzinga Newsdesk
Transphorm (NASDAQ:TGAN) reported Q4 sales of $3.20 million, missing the analyst consensus estimate of $4.67 million by 31.48 percent. This represents a 35.05 percent decrease from the same period last year.
June 27, 2023 | 8:32 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Transphorm's Q4 sales missed the analyst consensus estimate by 31.48 percent and decreased by 35.05 percent YoY.
Transphorm's Q4 sales missed the analyst consensus estimate by a significant margin and also showed a substantial decrease compared to the same period last year. This could negatively impact investor sentiment and potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100